Cargando…

Profile of specific antibodies to the SARS-CoV-2

In this work, we studied the profile of IgM and IgG antibody responses to SARS-CoV-2 in 32 patients with COVID-19 from day 1 to day 24. IgM remained measurable for a much shorter period than IgG, suggesting that IgG antibody may represent the primary immune response.

Detalles Bibliográficos
Autores principales:	Mou, Danlei, Feng, Huahua, Cao, Ruiyuan, Weng, Xing, Zhao, Lizhe, Yang, Lingling, Jin, Ronghua, Chen, Weijun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Microbiology Society 2021
Materias:	Clinical Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8346729/ https://www.ncbi.nlm.nih.gov/pubmed/33734961 http://dx.doi.org/10.1099/jmm.0.001335

Ejemplares similares

The Utility of Specific Antibodies Against SARS-CoV-2 in Laboratory Diagnosis
por: Fu, Yu, et al.
Publicado: (2021)

Innate Immunity Evasion Strategies of Highly Pathogenic Coronaviruses: SARS-CoV, MERS-CoV, and SARS-CoV-2
por: Li, Jin-Yan, et al.
Publicado: (2021)

Development of Fast and Portable Frequency Magnetic Mixing-Based Serological SARS-CoV-2-Specific Antibody Detection Assay
por: Pietschmann, Jan, et al.
Publicado: (2021)

Profile of specific antibodies to SARS-CoV-2: The first report
por: Xiao, Ai Tang, et al.
Publicado: (2020)

CDetection.v2: One-pot assay for the detection of SARS-CoV-2
por: Wang, Xinge, et al.
Publicado: (2023)

Oral SARS-CoV-2 Spike Protein Recombinant Yeast Candidate Prompts Specific Antibody and Gut Microbiota Reconstruction in Mice
por: Zhang, Lilin, et al.
Publicado: (2022)

Persistence of the SARS-CoV-2 Antibody Response in Asymptomatic Patients in Correctional Facilities
por: Tian, Xiaodong, et al.
Publicado: (2021)

Review of therapeutic mechanisms and applications based on SARS-CoV-2 neutralizing antibodies
por: Liu, Mingtao, et al.
Publicado: (2023)

Inflammatory Profiles of Tracheal Biopsies From SARS-CoV-2 Patients
por: Fiacchini, Giacomo, et al.
Publicado: (2022)

Inactivated Vaccines Against SARS-CoV-2: Neutralizing Antibody Titers in Vaccine Recipients
por: Zhang, Haiying, et al.
Publicado: (2022)

Re: Profile of specific antibodies to SARS-CoV-2: The first report
por: Zeng, Zhikun, et al.
Publicado: (2020)

Specificity and cross-reactivity of a test for anti-SARS-CoV-2 antibodies
por: Choy, Kay Weng
Publicado: (2021)

Anti-spike, Anti-nucleocapsid and Neutralizing Antibodies in SARS-CoV-2 Inpatients and Asymptomatic Individuals
por: Brochot, Etienne, et al.
Publicado: (2020)

Antibody and T Cell Immune Responses to SARS-CoV-2 Peptides in COVID-19 Convalescent Patients
por: Garanina, Ekaterina, et al.
Publicado: (2022)

Rapid and Specific Detection of Active SARS-CoV-2 With CRISPR/Cas12a
por: Liu, Xinyi, et al.
Publicado: (2022)

Molecular and cellular mechanisms involved in tissue-specific metabolic modulation by SARS-CoV-2
por: dos Santos, Alef Aragão Carneiro, et al.
Publicado: (2022)

Integrated Analysis Reveals the Characteristics and Effects of SARS-CoV-2 Maternal–Fetal Transmission
por: Huang, Ziliang, et al.
Publicado: (2022)

Development of an Automated Chemiluminescence Assay System for Quantitative Measurement of Multiple Anti-SARS-CoV-2 Antibodies
por: Kubo, Sousuke, et al.
Publicado: (2021)

Evidence of SARS-CoV-2 Antibodies and RNA on Autopsy Cases in the Pre-Pandemic Period in Milan (Italy)
por: Lai, Alessia, et al.
Publicado: (2022)

Antibodies to SARS-CoV-2 and their potential for therapeutic passive immunization
por: Klasse, PJ, et al.
Publicado: (2020)

SARS-CoV-2 and gastrointestinal diseases
por: Sha, Ailong, et al.
Publicado: (2023)

Protection from successive Omicron variants with SARS-CoV-2 vaccine and monoclonal antibodies in kidney transplant recipients
por: Moal, Valérie, et al.
Publicado: (2023)

Comparative Genomic Analyses Reveal a Specific Mutation Pattern Between Human Coronavirus SARS-CoV-2 and Bat-CoV RaTG13
por: Lv, Longxian, et al.
Publicado: (2020)

Evaluation of the presence of SARS-CoV-2 in vaginal and anal swabs of women with omicron variants of SARS-CoV-2 infection
por: Liu, Ding, et al.
Publicado: (2022)

A Rapid and Specific Assay for the Detection of MERS-CoV
por: Huang, Pei, et al.
Publicado: (2018)

Drug-induced phospholipidosis is not correlated with the inhibition of SARS-CoV-2 - inhibition of SARS-CoV-2 is cell line-specific
por: Diesendorf, Viktoria, et al.
Publicado: (2023)

Longitudinal analysis of SARS-CoV-2 reinfection reveals distinct kinetics and emergence of cross-neutralizing antibodies to variants of concern
por: Facciuolo, Antonio, et al.
Publicado: (2023)

The Potential Intermediate Hosts for SARS-CoV-2
por: Zhao, Jie, et al.
Publicado: (2020)

On the origin and continuing evolution of SARS-CoV-2
por: Tang, Xiaolu, et al.
Publicado: (2020)

MicroGMT: A Mutation Tracker for SARS-CoV-2 and Other Microbial Genome Sequences
por: Xing, Yue, et al.
Publicado: (2020)

In vitro Characterization of Fitness and Convalescent Antibody Neutralization of SARS-CoV-2 Cluster 5 Variant Emerging in Mink at Danish Farms
por: Lassaunière, Ria, et al.
Publicado: (2021)

SARS-CoV-2-specific T cells without antibodies
por: Bozkus, Cansu Cimen
Publicado: (2020)

Production of SARS-CoV-2 N Protein-Specific Monoclonal Antibody and Its Application in an ELISA-Based Detection System and Targeting the Interaction Between the Spike C-Terminal Domain and N Protein
por: Kim, Dongbum, et al.
Publicado: (2021)

In-Depth Bioinformatic Analyses of Nidovirales Including Human SARS-CoV-2, SARS-CoV, MERS-CoV Viruses Suggest Important Roles of Non-canonical Nucleic Acid Structures in Their Lifecycles
por: Bartas, Martin, et al.
Publicado: (2020)

Favorable vaccine-induced SARS-CoV-2–specific T cell response profile in patients undergoing immune-modifying therapies
por: Qui, Martin, et al.
Publicado: (2022)

SARS-CoV-2 symptomatic reinfection among patients with primary antibody deficiency
por: Marcus, Nufar, et al.
Publicado: (2022)

A comparison of 7 commercial anti-SARS-CoV-2 antibody immunoassays
por: Swadźba, Jakub, et al.
Publicado: (2020)

Comprehensive serologic profile and specificity of maternal and neonatal cord blood SARS-CoV-2 antibodies
por: Boelig, Rupsa C., et al.
Publicado: (2021)

IgA Antibodies and IgA Deficiency in SARS-CoV-2 Infection
por: Quinti, Isabella, et al.
Publicado: (2021)

SARS-CoV-2: Recent Variants and Clinical Efficacy of Antibody-Based Therapy
por: Singh, Desh Deepak, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_itnj59c1p5qmkk15fcgoc230ti